These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 5862993)

  • 41. The transfusion of HLA-matched platelets to thrombocytopenic patients resistant to random donor platelets.
    Levy L; Woodfield DG
    N Z Med J; 1984 Oct; 97(766):719-21. PubMed ID: 6595558
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treating thrombocytopenia with pathogen-reduced platelets.
    Sandler SG
    Curr Hematol Rep; 2006 Mar; 5(1):53-4. PubMed ID: 16537046
    [No Abstract]   [Full Text] [Related]  

  • 43. Platelet functions and clinical effects in acute myelogenous leukemia.
    Foss B; Bruserud O
    Thromb Haemost; 2008 Jan; 99(1):27-37. PubMed ID: 18217131
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Prevention of hemorrhagic complications in surgical interventions in the maxillofacial area in acute leukemia patients].
    Dmitrieva VS; Avanesov AM
    Vestn Khir Im I I Grek; 1984 Dec; 133(12):84-5. PubMed ID: 6528455
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Supplies for blood transfusions in dogs and cats.
    Kaufman PM
    Probl Vet Med; 1992 Dec; 4(4):582-93. PubMed ID: 1472769
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alloimmunization against the MHC antigens after platelet transfusions is due to contaminating leukocytes in the platelet suspension.
    Claas FH; Smeenk RJ; Schmidt R; van Steenbrugge GJ; Eernisse JG
    Exp Hematol; 1981 Jan; 9(1):84-9. PubMed ID: 7238645
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Therapy of acute leukemia. 2. Progress in supportive therapy].
    Miura M; Hirano M; Kakizawa H; Morita A; Ono R
    Saishin Igaku; 1971 Aug; 26(8):1586-92. PubMed ID: 5570226
    [No Abstract]   [Full Text] [Related]  

  • 48. [Ultrastructural and functional characteristics of blood platelets in blastic leukemia].
    Dobréva A; Ghénova V
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1973; 99(1):65-75. PubMed ID: 4121132
    [No Abstract]   [Full Text] [Related]  

  • 49. Guidelines for the administration of blood and blood products.
    D'Aguillo A; Plafker J; Ehrenberg B; Gal K; Kim DU; Kuriyan M; Muschenheim F; Nayak S; Napolitano J; Pachter IB; Roddy FL; Wake E
    J Med Soc N J; 1983 Jun; 80(6):437-43. PubMed ID: 6577194
    [No Abstract]   [Full Text] [Related]  

  • 50. Platelet dose consistency and its effect on the number of platelet transfusions for support of thrombocytopenia: an analysis of the SPRINT trial of platelets photochemically treated with amotosalen HCl and ultraviolet A light.
    Murphy S; Snyder E; Cable R; Slichter SJ; Strauss RG; McCullough J; Lin JS; Corash L; Conlan MG;
    Transfusion; 2006 Jan; 46(1):24-33. PubMed ID: 16398727
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical evaluation of platelet transfusions in thrombocytopenic patients: methods and interpretation.
    Kahn RA
    Vox Sang; 1981; 40 Suppl 1():87-97. PubMed ID: 7293125
    [No Abstract]   [Full Text] [Related]  

  • 52. A comparison of platelet production methods suitable for a service-oriented blood donor center.
    Koepke JA; Wu KK; Hoak JC; Thompson JS
    Transfusion; 1975; 15(1):39-42. PubMed ID: 1114512
    [No Abstract]   [Full Text] [Related]  

  • 53. [Macrophage injury--a new method of treating idiopathic thrombocytopenia].
    Kuratowska Z
    Pol Tyg Lek; 1982 May; 37(9-10):253-4. PubMed ID: 7111094
    [No Abstract]   [Full Text] [Related]  

  • 54. A less invasive treatment strategy to prevent intracranial hemorrhage in fetal and neonatal alloimmune thrombocytopenia.
    Radder CM; Brand A; Kanhai HH
    Am J Obstet Gynecol; 2001 Sep; 185(3):683-8. PubMed ID: 11568798
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Isolation and use of thrombocyte and leukocyte concentrates].
    Kalinin NN
    Probl Gematol Pereliv Krovi; 1980 Oct; 25(10):50. PubMed ID: 6999495
    [No Abstract]   [Full Text] [Related]  

  • 56. The role of commercial plasmapheresis banks on the AIDS epidemic in Mexico.
    Volkow P; Perez-Padilla R; del-Rio C; Mohar A
    Rev Invest Clin; 1998; 50(3):221-6. PubMed ID: 9763887
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Indications for labile blood products and the physiology of transfusion in surgery].
    Ozier Y; Mignon A; Rosencher N
    Transfus Clin Biol; 2005 Jun; 12(2):221-5. PubMed ID: 15950892
    [No Abstract]   [Full Text] [Related]  

  • 58. PLATELET TRANSFUSION THERAPY.
    SERPICK AA
    JAMA; 1965 May; 192():625-7. PubMed ID: 14284868
    [No Abstract]   [Full Text] [Related]  

  • 59. Platelet transfusion.
    Machin SJ; Kelsey H; Seghatchian MJ; Warwick R; Mackie IJ
    Thromb Haemost; 1995 Jul; 74(1):246-52. PubMed ID: 8578466
    [No Abstract]   [Full Text] [Related]  

  • 60. The platelet-refractory bone marrow transplant patient: prophylaxis and treatment of bleeding.
    Benson K; Fields K; Hiemenz J; Zorsky P; Ballester O; Perkins J; Elfenbein G
    Semin Oncol; 1993 Oct; 20(5 Suppl 6):102-9. PubMed ID: 8211211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.